- Home
- /
- Treatment
- /
- Page 25
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
Tadekinig alfa | Hemophagocytic lymphohistiocytosis | Coté Orphan Consulting UK Limited | October 14, 2016 |
|
Melatonin | Smith-Magenis syndrome | Therapicon Srl | October 14, 2016 |
|
Venetoclax | Multiple myeloma | AbbVie Ltd | October 14, 2016 |
|
Mogamulizumab | Cutaneous T-cell lymphoma | Kyowa Kirin Limited | October 14, 2016 |
|
2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{4-[4-(5-fluoro-pyrimidin-2-yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide | Invasive aspergillosis | F2G Ltd | October 14, 2016 |
|
P-ethoxy growth factor receptor-bound protein 2 antisense oligonucleotide | Acute myeloid leukaemia | Clinical Network Services (UK) Ltd | October 14, 2016 |
|
Adeno-associated viral vector serotype 2/2 containing a gene encoding the channelrhodopsin-2 protein | Retinitis pigmentosa | Allergan Pharmaceuticals International Limited | October 14, 2016 |
|
Radio-iodinated (131I) anti-CD45 murine monoclonal antibody | Treatment in haematopoietic stem cell transplantation | PharmaLex UK Services Limited | October 14, 2016 |
|
Adeno-associated viral vector serotype 5 containing the humanRLBP1gene | Retinitis pigmentosa | HORAMA SA | October 14, 2016 |
|
Self-complementary adeno-associated viral vector serotype 9 containing theSGSHgene | Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome) | Abeona Therapeutics Europe SL | October 14, 2016 |
|
Acebutolol hydrochloride | Smith-Magenis syndrome | Therapicon Srl | October 14, 2016 |
|
Tetrofosmin | Glioma | ProActina | October 14, 2016 |
|
Autologous mononuclear cells derived from human cord blood | Neonatal encephalopathy | BrainRepair UG (haftungsbeschränkt) | October 14, 2016 |
|
Ubiquinol | Primary coenzyme Q10deficiency syndrome | Consorcio Centro de Investigación Biomédica en Red M.P. | October 14, 2016 |
|
A non-covalent trimer of tumour necrosis factor fused to an antibody specific to the extra-domain B of fibronectin in single-chain variable fragment format | Soft tissue sarcoma | Philogen S.p.A. | October 14, 2016 |
|
Autologous mononuclear cells derived from human cord blood | Leukomalacia | BrainRepair UG (haftungsbeschränkt) | October 14, 2016 |
|
Venetoclax | Diffuse Large B-cell Lymphoma | AbbVie Ltd | October 14, 2016 |
|
Crenolanib besylate | Soft tissue sarcoma | Arog Pharmaceuticals Europe Ltd | October 14, 2016 |
|
Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 | Diffuse Large B-cell Lymphoma | Novartis Europharm Limited | October 14, 2016 |
|
Xenon | Ischaemia reperfusion injury associated with cardiac arrest | Neuroprotexeon Ltd | October 14, 2016 |
|
Chemically modified human recombinant sulfamidase | Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome) | Swedish Orphan Biovitrum AB (publ) | October 14, 2016 |
|
(6aR,10aR)-3-(1′,1′-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid | Cystic fibrosis | TMC Pharma Services Ltd | October 14, 2016 |
|
Crenolanib besylate | Acute myeloid leukemia | Arog Pharmaceuticals Europe Ltd | October 14, 2016 |
|
(E)-(6-((N-methyl-((3-methylbenzofuran-2-yl)methyl)amino)-3-oxoprop-1-en-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2H)-yl)methyl phosphate, bis ethanolamine salt | Osteomyelitis | Voisin Consulting S.A.R.L. | October 14, 2016 |
|
Exendin (9-39) | Noninsulinoma pancreatogenous hypoglycaemia syndrome | Eiger Biopharmaceuticals Europe Limited | October 14, 2016 |
